Sunesis Pharmaceuticals (SNSS) stock price has skyrocketed over 20% in intraday: Things you need to know.
The shares of Sunesis Pharmaceuticals (SNSS), a biopharmaceutical company that aims to treat hematologic and solid cancers, have skyrocketed after the Oppenheimer analyst Hartaj Singh upgraded the stock from perform to outperform and has set a price target of $12 which points to an upside of over 230%. It last finished at $5.32, fluctuating in […]
